Early Donor-Derived Cell-Free DNA Kinetics After Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Preliminary Observational Study. [PDF]
Wawrzonkowski P +9 more
europepmc +1 more source
Beyond CA-125: circulating cell-free DNA as the next-generation biomarker in ovarian malignancy. [PDF]
Elgedawy GA +6 more
europepmc +1 more source
Validation of the TransplantTrace cfDNA Kidney assay for measurement of donor-derived cell-free DNA in transplant recipients. [PDF]
Berg M +7 more
europepmc +1 more source
Genome-Wide Prenatal cfDNA Screening and the Obstetric Incidentalome: Maternal Cancer, Placental Mosaicism, and Pregnancy Risk. [PDF]
Xu M, Liu Y, Gao M, Zhu Y.
europepmc +1 more source
Circulating tumor DNA for minimal residual disease and recurrence surveillance in hepatocellular carcinoma: current evidence and a translational roadmap. [PDF]
Gu Y, Luo X, Zhang Y, Tang J, Wang Z.
europepmc +1 more source
Uncovering the diagnostic potential of seminal fluid beyond fertility: cfDNA methylation analysis for the detection of clinically significant prostate cancer. [PDF]
Geis J +14 more
europepmc +1 more source
DNAmBERT: a transformer-based model for non-invasive cancer diagnosis using DNA sequence and methylation data. [PDF]
Yassi M +5 more
europepmc +1 more source
A Prospective, Multi-Site Study of Performance of Cell-Free DNA Testing for Recessive Conditions in a Large, General-Risk Pregnancy Population. [PDF]
McElwee ER +24 more
europepmc +1 more source
Epigenetic Liquid Biopsy Enables Universal Mutation-Agnostic Molecular Surveillance for High-Risk Neuroblastoma. [PDF]
Gal-Mark N +16 more
europepmc +1 more source
Circulating NETosis biomarkers predict severity, 12-month functional outcome, and survival after spontaneous intracerebral hemorrhage. [PDF]
Hu C +5 more
europepmc +1 more source

